Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Importantly, fusing MCP to the N-terminus of ADARs did not affect their editing activity as measured with an A-to-I-editing-dependent NanoLuc reporter [67] (Supplementary Fig. S6A), nor their subcellular localization (Supplementary Fig. S6B), nor protein stability and abundance (Supplementary Fig. S6C and D).”
From ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability (2026) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Higuchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., & Seeburg, P. H. (2000) · Nature · doi:10.1038/35017558 · Cited by 967
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923 · cited 2×
“Furthermore, mutations in the ADAR1 gene cause Aicardi-Goutières syndrome, which is a fatal autoimmune disease in children caused by an upregulation of ISGs (12).”
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers
Han, L., Diao, L., Yu, S., Xu, X., Li, J., Zhang, R., Yang, Y., Werner, H. M. J., Eterovic, A. K., Yuan, Y., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.08.013 · Cited by 542 · cited 2×
“Next generation sequencing and The Cancer Genome Atlas (TCGA) have detected a substantial number of alterations in A-to-I editing in many different cancer types (37,14,15).”
Background
Research works printed but not linked: 39
- Hartner, 2004, Liver disintegration in the mouse embryo caused by deficiency in the RNA-editing enzyme ADAR1, J. Biol. Chem., 279, 4894, 10.1074/jbc.M311347200 · DOI · Paper page
- Wang, 2004, Stress-induced apoptosis associated with null mutation of ADAR1 RNA editing deaminase gene, J. Biol. Chem., 279, 4952, 10.1074/jbc.M310162200 · DOI · Paper page
- Behm, 2016, RNA Editing: a contributor to neuronal dynamics in the mammalian brain, Trends Genet., 32, 165, 10.1016/j.tig.2015.12.005 · DOI
- Eggington, 2011, Predicting sites of ADAR editing in double-stranded RNA, Nat. Commun., 2, 1, 10.1038/ncomms1324 · DOI · Paper page
- Lehmann, 2000, Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities, Biochemistry, 39, 12875, 10.1021/bi001383g · DOI · Paper page
- Hartner, 2009, ADAR1 is essential for the maintenance of hematopoiesis and suppression of interferon signaling, Nat. Immunol., 10, 109, 10.1038/ni.1680 · DOI · Paper page
- Patterson, 1995, Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase, Mol. Cell. Biol., 15, 5376, 10.1128/MCB.15.10.5376 · DOI · Paper page
- Vitali, 2010, Double-stranded RNAs containing multiple IU pairs are sufficient to suppress interferon induction and apoptosis, Nat. Struct. Mol. Biol., 17, 1043, 10.1038/nsmb.1864 · DOI · Paper page
- Mannion, 2014, The RNA-editing enzyme ADAR1 controls innate immune responses to RNA, Cell Rep., 9, 1482, 10.1016/j.celrep.2014.10.041 · DOI · Paper page
- Pestal, 2015, Isoforms of RNA-Editing enzyme ADAR1 independently control nucleic acid sensor MDA5-Driven autoimmunity and Multi-organ development, Immunity, 43, 933, 10.1016/j.immuni.2015.11.001 · DOI · Paper page
- Fritzell, 2018, ADARs and editing: the role of A-to-I RNA modification in cancer progression, Semin. Cell Dev. Biol., 79, 123, 10.1016/j.semcdb.2017.11.018 · DOI
- Paz-Yaacov, 2015, Elevated RNA editing activity is a major contributor to transcriptomic diversity in tumors, Cell Rep., 13, 267, 10.1016/j.celrep.2015.08.080 · DOI · Paper page
- Maas, 2001, Underediting of glutamate receptor GluR-B mRNA in malignant gliomas, Proc. Natl. Acad. Sci. U.S.A., 98, 14687, 10.1073/pnas.251531398 · DOI · Paper page
- Anadon, 2016, Gene amplification-associated overexpression of the RNA editing enzyme ADAR1 enhances human lung tumorigenesis, Oncogene, 35, 4407, 10.1038/onc.2015.469 · DOI
- Chan, 2014, A disrupted RNA editing balance mediated by ADARs (Adenosine DeAminases that act on RNA) in human hepatocellular carcinoma, Gut, 63, 832, 10.1136/gutjnl-2012-304037 · DOI · Paper page
- Chan, 2016, ADAR-mediated RNA editing predicts progression and prognosis of gastric cancer, Gastroenterology, 151, 637, 10.1053/j.gastro.2016.06.043 · DOI · Paper page
- Qin, 2014, Adenosine-to-inosine RNA editing mediated by ADARs in esophageal squamous cell carcinoma, Cancer Res., 74, 840, 10.1158/0008-5472.CAN-13-2545 · DOI · Paper page
- Nakano, 2017, A-to-I RNA editing Up-regulates human dihydrofolate reductase in breast cancer, J. Biol. Chem., 292, 4873, 10.1074/jbc.M117.775684 · DOI
- Masser, 2016, Luciferase NanoLuc as a reporter for gene expression and protein levels in Saccharomyces cerevisiae, Yeast, 33, 191, 10.1002/yea.3155 · DOI
- Kaimal, 2017, Coordinated Hsp110 and Hsp104 activities power protein disaggregation in saccharomyces cerevisiae, Mol. Cell. Biol., 37, e00027-17, 10.1128/MCB.00027-17 · DOI
- Desterro, 2003, Dynamic association of RNA-editing enzymes with the nucleolus, J. Cell Sci., 116, 1805, 10.1242/jcs.00371 · DOI · Paper page
- Bratt, 2003, Coordination of editing and splicing of glutamate receptor pre-mRNA, RNA, 9, 309, 10.1261/rna.2750803 · DOI
- Ohlson, 2007, Editing modifies the GABA(A) receptor subunit alpha3, RNA, 13, 698, 10.1261/rna.349107 · DOI · Paper page
- Newnam, 1999, Antagonistic interactions between yeast chaperones Hsp104 and Hsp70 in prion curing, Mol. Cell. Biol., 19, 1325, 10.1128/MCB.19.2.1325 · DOI · Paper page
- Woods, 2001, High-efficiency transformation of plasmid DNA into yeast, Methods Mol. Biol., 177, 85
- Silve, 1991, Membrane insertion of uracil permease, a polytopic yeast plasma membrane protein, Mol. Cell. Biol., 11, 1114, 10.1128/MCB.11.2.1114 · DOI
- Zhang, 1999, A simple statistical parameter for use in evaluation and validation of high throughput screening assays, J. Biomol. Screen, 4, 67, 10.1177/108705719900400206 · DOI · Paper page
- Gommans, 2010, A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels, Anal. Biochem., 399, 230, 10.1016/j.ab.2009.12.037 · DOI
- Wang, 2016, Probing RNA recognition by human ADAR2 using a high-throughput mutagenesis method, Nucleic Acids Res., 44, 9872, 10.1093/nar/gkw799 · DOI
- Garncarz, 2013, A high-throughput screen to identify enhancers of ADAR-mediated RNA-editing, RNA Biol., 10, 192, 10.4161/rna.23208 · DOI · Paper page
- Jepson, 2011, Visualizing adenosine-to-inosine RNA editing in the Drosophila nervous system, Nat. Methods, 9, 189, 10.1038/nmeth.1827 · DOI
- Montiel-Gonzalez, 2016, An efficient system for selectively altering genetic information within mRNAs, Nucleic Acids Res., 44, e157
- Eifler, 2012, A screening protocol for identification of functional mutants of RNA editing adenosine deaminases, Curr. Protoc. Chem. Biol., 4, 357, 10.1002/9780470559277.ch120139 · doi:10.1002/9780470559277.ch120139
- Fumagalli, 2015, Principles governing A-to-I RNA editing in the breast cancer transcriptome, Cell Rep., 13, 277, 10.1016/j.celrep.2015.09.032 · DOI · Paper page
- Walker, 2017, Highly potent Cell-Permeable and impermeable NanoLuc luciferase inhibitors, ACS Chem. Biol., 12, 1028, 10.1021/acschembio.6b01129 · DOI
- Veliz, 2003, Substrate analogues for an RNA-editing adenosine deaminase: mechanistic investigation and inhibitor design, J. Am. Chem. Soc., 125, 10867, 10.1021/ja029742d · DOI
- Zipeto, 2016, ADAR1 activation drives leukemia stem cell Self-Renewal by impairing Let-7 biogenesis, Cell Stem. Cell, 19, 177, 10.1016/j.stem.2016.05.004 · DOI · Paper page
- Crow, 2008, Aicardi-Goutieres syndrome: an important Mendelian mimic of congenital infection, Dev. Med. Child Neurol., 50, 410, 10.1111/j.1469-8749.2008.02062.x · DOI · Paper page
- Hall, 2012, Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate, ACS Chem. Biol., 7, 1848, 10.1021/cb3002478 · DOI · Paper page
Cited by
A chimeric viral platform for directed evolution in mammalian cells
Cole, A. J., Denes, C. E., Moreno, C. L., Hunault, L., Dobson, T., Hesselson, D., & Neely, G. G. (2025) · Nature Communications · doi:10.1038/s41467-025-59438-2 · Cited by 7
ADAR1 and ADAR2 associate with the RNA exosome and modulate RNA stability
Vukić, D., Du, Q., Cherian, A., Amoruso, D., Brožinová, K., Wacheul, L., Lacovich, V., Zorbas, C., Yadav, L., Sedmík, J., et al. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag381
Metadata
- Authors
- Fritzell, K., Xu, L.-D., Otrocka, M., Andréasson, C., & Öhman, M.
- Affiliations
- Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Svante Arrhenius väg 20C, 106 91 Stockholm, Sweden
- Chemical Biology Consortium Sweden, Science for Life Laboratory, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77, Stockholm, Sweden
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-12-22
- Volume
- 47
- Issue
- 4
- Pages
- e22-e22
- ISSN
- 0305-1048
- 1362-4962
- Cited by
- 42
- References
- 3
- Language
- en
- Funders
- Swedish research council (2015–05094, K2013-66X-20702, K2013-66X20702)
- Swedish Cancer Society (CAN 2016/361)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.